Patients taking a loop diuretic can be considered relevant for a medicines use review (MUR) if they fall into the national target group of patients who are at risk of, or have been diagnosed with, cardiovascular disease and are regularly being prescribed at least four medicines.
They can also fall into the target group for post-discharge reviews, following the transition of a patient taking two or more medicines from hospital to community care.
What to know before advising patients
Loop diuretics are a group of diuretics (furosemide and bumetanide) that cause powerful diuresis (more powerful than the diuresis caused by thiazide diuretics).
To understand the mechanism of action, it is important to understand some of the kidney’s functions. The kidney is made up of nephrons that